查詢結果分析
相關文獻
- Iliopsoas Hematoma with Compressive Femoral Neuropathy Complicating Warfarin Prophylaxis: A Case Report
- 抗凝血劑治療病患接受上消化道胃腸道鏡檢後發生十二指腸腸壁血腫與後腹腔出血--病例報告
- Colon Obstruction Due to Anticoagulant Induced Intramural Hematoma
- Anticoagulant-Induced Intramural Hematoma of Small Bowel: Report of a Case
- Spontaneous Psoas Muscle Hematoma: A Case Report and Literature Review
- Spontaneous Intramural Small Bowel Hematoma Associated with Warfarin Nonadherence: A Case Report
- Moyamoya Disease Causes Acute Subdural Hematomas and Sudden Death: A Case Report
- Epiglottic Hematoma Secondary to Endotracheal Intubation
- 創傷之延遲性硬腦膜外血腫
- 淺談口服抗凝血劑 Warfarin 藥理及藥效特性
頁籤選單縮合
題名 | Iliopsoas Hematoma with Compressive Femoral Neuropathy Complicating Warfarin Prophylaxis: A Case Report=髂肌血腫合併壓迫性股神經病變 |
---|---|
作者 | 黃健洲; 李孝倫; 沈萬豐; 黃炳文; Huang, Chien-chou; Lee, Xiao-lun; Shen, Wan-feng; Huang, Ping-wun; |
期刊 | 中華民國急救加護醫學會雜誌 |
出版日期 | 20111200 |
卷期 | 22:4 2011.12[民100.12] |
頁次 | 頁158-163 |
分類號 | 418.2321 |
語文 | eng |
關鍵詞 | 血腫; 華法林; 抗凝血劑; 股神經病變; 維它命K結抗劑; Hematoma; Warfarin; Anticoagulation; Femoral nerve neuropathy; Vitamin K antagonist; |
中文摘要 | 接受心臟金屬瓣膜置換的患者往往需要終身服用抗凝劑,然而服用抗凝劑便可能有過渡抗凝及出血的可能性。病例報告:一位 61歲的亞洲男性因非創傷性左側腰痛及左下肢無力被送至急診室,他過去因接受心臟金屬瓣膜置換長期服用香豆素,經電腦斷層及神經學檢查後發現病患罹患髂肌血腫合併壓迫性神經病變,凝血功能檢查發現凝血脢原時間及部分凝血脢原時間延長,我們回顧文獻並分析長時間服用低劑量香豆素造成國際標準化比值 (INR)延長及出血傾向的因素。結論:影響 INR的因素很多,既使是服用長期低劑量香豆素仍須定期監測 INR以避免香豆素造成過渡抗凝。 |
英文摘要 | Patients who have received mechanical heart valves usually have to take lifelong prophylactic anticoagulants. Inattention to treatment with low dose prophylactic anticoagulants may result in overanticoagulation and increase the risk of bleeding. A 61-year-old Asian man who had a mechanical heart valve and was receiving warfarin presented in the emergency room with non-traumatic spontaneousleft lower back pain and left leg weakness on walking for one day. Abdominal computed tomography imaging and neurological examination confirmed a left iliopsoas hematoma with compressive femoralneuropathy. A coagulation profile showed prolonged prothrombin and partial thrombin times. Prophylactic anticoagulation was immediately suspended and the patient was treated with an oral pain reliever andintravenous Vitamin K injections. The patient’s condition improved after treatment and the coagulation profile was within the normal limits on follow-up. The patient was discharged and periodic assessmentof the coagulation profile was arranged. Our case study investigated factors contributing to an increased international normalized ratio (INR) in relation to bleeding in patients on long term, low dose warfarinprophylaxis. We concluded that periodic INR monitoring is still mandatory to prevent bleeding caused by over-anticoagulation in patients on long term, low-dose warfarin prophylaxis. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。